Loading…
Loading grant details…
| Funder | European Commission |
|---|---|
| Recipient Organization | Luxembourg Institute of Science and Technology |
| Country | Luxembourg |
| Start Date | Mar 01, 2021 |
| End Date | Aug 31, 2025 |
| Duration | 1,644 days |
| Number of Grantees | 11 |
| Roles | Participant; Coordinator; Third Party |
| Data Source | European Commission |
| Grant ID | 953110 |
Nano-pharmaceuticals have the potential to drive the scientific and technological uplift, offering great clinical and socio-economic benefits to the society in general, industry and key stakeholders and patients.
Nevertheless, affordable and advanced testing, manufacturing facilities and services for novel nano-pharmaceuticals are main prerequisites for successful implementation of these advances to further enhance the growth and innovation capacity.
The establishment of current good manufacturing practice (cGMP) in nano-pharmaceutical production at large scale is the key step to transfer successfully the nano-pharmaceuticals from bench to bedside (from lab to industrial scale).
Due to the lack of resources to implement GMP manufacturing at-site, the upscaling and production of innovative nano-pharmaceuticals is still challenging to main players of EU nanomedicine market, start-ups and SMEs.
To allow successful implementation of the nano-pharmaceuticals in the nanomedicine field, there is an urgent need to establish science- and regulatory-based Open Innovation Test Bed (OITB).
Phoenix aims to enable the seamless, timely and cost-friendly transfer of nano-pharmaceuticals from lab bench to clinical trials by providing the necessary advanced, affordable and easily accessible Phoenix-OITB.
Phoenix-OITB will offer a consolidated network of facilities, technologies, services and expertise for all the technology transfer aspects from characterization, testing, verification up to scale up, GMP compliant manufacturing and regulatory guidance.
Phoenix-OITB will develop and establish new facilities and upgrade existing ones to make them available to SMEs, starts-up and research laboratories for scale-up, GMP production and testing of nano-pharmaceuticals.
The services and expertise provided by the OITB will include production and characterization under GMP conditions, safety evaluation, regulatory compliance and commercialisation boost.
Mybiotech Gmbh; Topas Therapeutics Gmbh; Institut Za Medicinska Istrazivanja I Medicinu Rada; Nanomol Technologies Sl; Research Center Pharmaceutical Engineering Gmbh; Luxembourg Institute of Science and Technology; Agencia Estatal Consejo Superior de Investigaciones Cientificas; Bionanonet Forschungsgesellschaft Mbh; Wageningen University; Leanbio Sl; Research Center for Non Destructive Testing Gmbh
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant